Campylobacter jejuni proteomics for new travellers' diarrhoea vaccines

Travel Medicine and Infectious Disease

Volumn 5, Issue 2 SPEC. ISS., 2007, Pages 106-109

  Schrotz King, P ^a   Prokhorova, T A ^a   Nielsen, P N ^a   Crawford, J S ^a   Morsczeck, C ^a  

^a ACE BioSciences AS   (Denmark)

Author keywords

Campylobacter jejuni; Drug discovery; Proteomics; Travellers' diarrhoea; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL PROTEIN; BACTERIAL VACCINE; CAMPYLOBACTER JEJUNI PROTEIN VACCINE; CHOLERA VACCINE; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; FLAGELLIN; GATIFLOXACIN; LEVOFLOXACIN; LIVE VACCINE; MOXIFLOXACIN; PROTEIN ACE 393; PROTEIN ACE 83; PROTEIN PEG1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CAMPYLOBACTER JEJUNI; CELL SURFACE; CLINICAL FEATURE; DRUG EFFICACY; DRUG QUALITY; DRUG RESEARCH; DRUG TARGETING; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; TRAVELLER DIARRHEA; VACCINE PRODUCTION;

EID: 33846868663     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2006.01.019     Document Type: Article

References (14)

1. Ericsson C.D. Traveller's diarrhoea. Int J Antimicrob Agents 21 (2003) 116-124
2. Steffen R. Epidemiologic studies of travelers' diarrhea, severe gastrointestinal infections, and cholera. Rev InfectDis 8 Suppl. 2 (1986) S122-S130
3. DuPont H.L., and Ericsson C.D. Prevention and treatment of travelers' diarrhea. N Eng J Med 328 (1993) 1821-1827
4. Leggat P.A., and Goldsmid J.M. Travellers' diarrhoea: health advice for travellers. Travel Med Infect Dis 2 (2004) 17-22
5. Pickering L.K. Antimicrobial resistance among enteric pathogens. Semin Pediatr Infect Dis 15 2 (2004) 71-77
6. World Health Organization, Campylobacter. 2000. http://www.who.int/mediacentre/factsheets/fs255/en/
7. Walker R.I. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine 23 (2005) 3369-3385
8. Rudi K., Hoidal H.K., Katla T., Johansen B.K., Nordal J., and Jakobsen K.S. Direct real-time PCR quantification of Campylobacter jejuni in chicken fecal and cecal samples by integrated cell concentration and DNA purification. Appl Environ Microbiol 7 (2004) 790-797
9. Oliveira T.C., Barbut S., and Griffiths M.W. A robotic DNA purification protocol and real-time PCR for the detection of Campylobacter jejuni in foods. J Food Prot 68 (2005) 2131-2135
10. Smith K.E., Besser J.M., et al. Quinolone-resistant Campylobacter jejuni infections in Minnesolta, 1992-1998. N Engl J Med 340 (1999) 1525-1532
11. Ziprin R.L., Hume M.E., Young C.R., and Harvey R.B. Inoculation of chicks with viable non-colonizing strains of Campylobacter jejuni: evaluation of protection against a colonizing strain. Curr Microbiol 44 3 (2002) 221-223
12. Burr D.H., Rollins D., Lee L.H., Pattarini D.L., Walz S.S., Tian J.H., et al. Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine. Vaccine 23 34 (2005) 4315-4321
13. Scott D.A. Vaccines against Campylobacter jejuni. J Infect Dis 176 Suppl 2 (1997) S183-S188
14. Endtz H.P., Ruijs G.J., Zwinderman A.H., van der Reijden T., Biever M., and Mouton R.P. Comparison of six media, including a semisolid agar, for the isolation of various Campylobacter species from stool specimens. J Clin Microbiol 29 5 (1991) 1007-1010